Report cover image

U.S. X-ray Irradiation Market Size, Share, Trends, Industry Analysis Report By Application (Medical Devices, Pharmaceuticals, Biotech & Laboratory Supplies, Others), By Size – Market Forecast, 2025–2034

Published Jul 01, 2025
Length 130 Pages
SKU # PLRS20324548

Description

The U.S. X-ray irradiation market size is expected to reach USD 1,052.45 million by 2034, according to a new study by Polaris Market Research. The report “U.S. X-ray Irradiation Market Size, Share, Trends, Industry Analysis Report By Application (Medical Devices, Pharmaceuticals, Biotech & Laboratory Supplies, Others), By Size – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. X-ray irradiation market focuses on the development, manufacturing, and distribution of systems that use X-rays to expose various materials and biological samples to controlled doses of radiation. This technology offers a safer and more environmentally friendly alternative to traditional gamma irradiation, which relies on radioactive isotopes such as Cesium-137. Key applications of X-ray irradiation include the sterilization of medical devices, pharmaceutical products, and laboratory supplies. They are also used in scientific research, such as creating immunocompromised animal models and inactivating pathogens in blood products. The market also includes services related to the installation, maintenance, and validation of these advanced irradiation systems.

The U.S. X-ray irradiation market is experiencing significant growth, driven by a strong emphasis on enhanced safety protocols and increasingly stringent regulatory requirements for sterilization and radiation handling. There is a trend toward replacing older, radioactive irradiators with modern and digital X-ray systems, spurred by initiatives aimed at reducing the global reliance on hazardous radioactive materials. The expanding healthcare sector, marked by a rising number of surgical procedures, organ transplants, and cancer treatments, fuels the demand for sterile medical supplies and safely irradiated blood components. Furthermore, ongoing advancements in X-ray technology, leading to more efficient, precise, and compact systems, are broadening the adoption of X-ray irradiation across diverse applications in research and industry.

U.S. X-ray Irradiation Market Report Highlights

By application, the medical devices segment held the largest share in 2024, primarily due to the critical need for sterile medical instruments and products.

By size, the large-scale segment held the largest share in 2024, driven by its capacity to handle high volumes of products for industrial and centralized sterilization needs.

A few key players in the market include Rad Source Technologies, Xstrahl, Best Theratronics (TeamBest Global), Hitachi, Comet (Comet Group), Nordion (Sterigenics International LLC), IBA Industrial (IBA SA), Phoenix Nuclear Labs, Resonetics, and NRT (National Recovery Technologies).

Polaris Market Research has segmented the U.S. X-ray irradiation market report on the basis of application and size:

By Application Outlook (Revenue – USD Million, 2020–2034)

Medical Devices

Pharmaceuticals

Biotech & Laboratory Supplies

Others

By Size Outlook (Revenue – USD Million, 2020–2034)

Small-scale

Mid-scale

Large-scale

Table of Contents

130 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. X-ray Irradiation Market Insights
4.1. U.S. X-ray Irradiation Market – Market Snapshot
4.2. U.S. X-ray Irradiation Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Shift from Radioactive Isotope Systems
4.2.1.2. Rising Healthcare and Medical Applications
4.2.2. Restraints and Challenges
4.2.2.1. Combination of consumer skepticism plus regulatory complexity
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. X-ray Irradiation Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. U.S. X-ray Irradiation Market, by Application
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. X-ray Irradiation Market, by Application, 2020–2034 (USD Million)
5.3. Medical Devices
5.3.1. U.S. X-ray Irradiation Market, by Medical Devices, by Region, 2020–2034 (USD Million)
5.4. Pharmaceuticals
5.4.1. U.S. X-ray Irradiation Market, by Pharmaceuticals, by Region, 2020–2034 (USD Million)
5.5. Biotech & Laboratory Supplies
5.5.1. U.S. X-ray Irradiation Market, by Biotech & Laboratory Supplies, by Region, 2020–2034 (USD Million)
5.6. Others
5.6.1. U.S. X-ray Irradiation Market, by Others, by Region, 2020–2034 (USD Million)
6. U.S. X-ray Irradiation Market, by Size
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. X-ray Irradiation Market, by Size, 2020–2034 (USD Million)
6.3. Small-scale
6.3.1. U.S. X-ray Irradiation Market, by Small-scale, by Region, 2020–2034 (USD Million)
6.4. Mid-scale
6.4.1. U.S. X-ray Irradiation Market, by Mid-scale, by Region, 2020–2034 (USD Million)
6.5. Large-scale
6.5.1. U.S. X-ray Irradiation Market, by Large-scale, by Region, 2020–2034 (USD Million)
7. Competitive Landscape
7.1. Expansion and Acquisition Analysis
7.1.1. Expansion
7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
8.1. Best Theratronics (TeamBest Global)
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Recent Development
8.2. Comet (Comet Group)
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Recent Development
8.3. Hitachi
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Recent Development
8.4. IBA Industrial (IBA SA)
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Recent Development
8.5. NRT (National Recovery Technologies)
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Development
8.6. Nordion (Sterigenics International LLC)
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Recent Development
8.7. Phoenix Nuclear Labs
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Recent Development
8.8. Rad Source Technologies
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Recent Development
8.9. Resonetics
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Recent Development
8.10. Xstrahl
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.